Latest News and Press Releases

Canton, CT, June 3, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc, (OTC: KLYG), a prominent manufacturer of custom cranial implants, today reported that the company generated net income of $71,205 in...

Canton, CT, April 7, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc.(OTC: KLYG), a manufacturer of custom cranial implants, announces preliminary revenue of $1,857,516 for 2013. This represents an...

Canton, CT, April 2, 2014 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. has introduced a new product to the marketplace, the "IFS" (Integrated Fixation System) product.  The product is patent pending...

Canton, CT, Nov. 5, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG) has successfully resolved the lawsuit with former employee John Mastoloni.  Per terms of the settlement agreement,...

Canton, CT, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc. (OTC: KLYG) ("the company") is pleased to announce that it has posted its first ever quarterly profit, for the quarter ending June...

Canton, CT, May 30, 2013 (GLOBE NEWSWIRE) -- Kelyniam Global Inc.  (OTC: KLYG), a growing company that designs, manufactures, and sells custom cranial/craniofacial implants, announced today its...

Canton, CT, Jan. 29, 2013 (GLOBE NEWSWIRE) -- (OTC: KLYG) Kelyniam Custom Cranial Implants, designed to fill the boney void in a patient's skull, have been endorsed by Mario Ammirati, MD, Director of...

Canton, CT, Jan. 15, 2013 (GLOBE NEWSWIRE) -- Third Quarter Kelyniam is pleased to announce record quarterly revenues of $382,177 for the third quarter ending September 30th 2012.  This...

Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Second Quarter Results Kelyniam Global Inc. (OTC: KLYG) For the quarter ending June 30th 2012 Kelyniam Global Inc. reported a loss of $45,692...

Canton, CT, Oct. 15, 2012 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), today announced that the U.S. Food and Drug Administration (FDA) has granted the company authorization to market Custom...